Lupus doesn’t have a single cause. It develops when a combination of genetic vulnerability, hormonal factors, and environmental triggers pushes the immune system into attacking the body’s own tissues. No one factor is enough on its own, which is why researchers describe lupus as a “threshold” disease: it takes multiple hits, accumulating over time, before the immune system tips into self-attack.
Understanding these overlapping causes helps explain why lupus affects certain people more than others, why it can seem to appear out of nowhere, and why it runs in some families but skips others.
Genetics Set the Stage
Lupus is not directly inherited like eye color, but having a close relative with the disease raises your risk significantly. Studies of identical twins show that if one twin develops lupus, the other has roughly a 25 to 50 percent chance of developing it too. That’s far higher than the general population, but well below 100 percent, which tells us genes matter but aren’t the whole story.
Dozens of gene variants have been linked to lupus risk, and most of them affect how the immune system handles two key jobs: clearing dead cells and regulating inflammation. One well-studied gene, IRF5, controls the production of proteins called type I interferons, which are part of the body’s antiviral defense system. Certain variants of IRF5 produce a more stable version of its protein, which can lead to an overactive interferon response. Another gene, STAT4, makes immune cells more sensitive to interferon signaling and has been tied to more severe forms of the disease. Variants in a region of the genome called HLA, which helps the immune system distinguish “self” from “foreign,” also contribute.
None of these gene variants guarantee lupus. Each one nudges the immune system a little closer to the edge. A person who inherits several of these variants has a higher baseline risk, but they still typically need an environmental or hormonal push to develop the disease.
Why Lupus Overwhelmingly Affects Women
About 9 out of 10 people with lupus are women, and that gap has long been attributed to estrogen. Estrogen does play a role: it stimulates the immune system by boosting the activity of cells that present foreign material to the rest of the immune system, increasing levels of inflammatory signaling molecules, and even promoting the production of antibodies that attack the body’s own DNA. Early onset of menstruation is associated with increased lupus risk, and flares commonly coincide with hormonal shifts.
But hormones aren’t the full explanation. Research using specially engineered mice showed that animals with two X chromosomes were more susceptible to lupus than those with one X, regardless of whether they had ovaries or testes. In other words, the number of X chromosomes mattered independently of sex hormones. Human data backs this up: men with Klinefelter syndrome, who carry an extra X chromosome (XXY), develop lupus at roughly 14 times the rate of typical XY men, reaching a risk level similar to women. Women with Triple X syndrome (XXX) have about 2.5 times the lupus prevalence of typical XX women. And women with Turner syndrome, who have only one X chromosome, have lower lupus risk.
The X chromosome carries a number of immune-related genes. Having more copies appears to increase the dosage of those genes, tipping the immune system toward overactivity.
Sunlight and UV Radiation
Ultraviolet light is one of the most consistent environmental triggers for lupus flares, and it may also play a role in initial onset. When UV rays penetrate the skin, they damage the DNA inside skin cells, triggering those cells to die through a process called apoptosis. Normally, the immune system quietly cleans up dead cells. But in people with lupus or a genetic predisposition to it, this cleanup process is impaired. Fragments of nuclear material from the dying cells accumulate and are recognized by the immune system as foreign, prompting an antibody response against the body’s own tissues.
UV exposure also disrupts the skin’s immune environment by depleting certain immune cells in the outer skin layers and altering the balance of regulatory cells that normally keep inflammation in check. For someone whose immune system is already primed to overreact, a bad sunburn can be enough to trigger a systemic flare.
Epstein-Barr Virus and Molecular Mimicry
Nearly all adults have been infected with Epstein-Barr virus (EBV), the virus that causes mono. But people with lupus are infected at even higher rates, and their immune response to the virus looks different from that of healthy people. The leading theory is molecular mimicry: a viral protein called EBNA-1, produced during EBV infection, is structurally similar enough to certain human proteins that antibodies made to fight the virus accidentally target the body’s own tissues.
In healthy people, the immune system produces a limited response to EBNA-1 and moves on. In people genetically predisposed to lupus, the response doesn’t stay contained. The immune system generates cross-reactive antibodies that begin attacking proteins associated with lupus, including Ro and Sm. Over time, these antibodies diversify through a process called epitope spreading, targeting additional self-proteins they weren’t originally aimed at. This gradual expansion may explain why lupus autoantibodies can be detected in blood years before clinical symptoms appear.
Workplace and Lifestyle Exposures
Crystalline silica, a mineral dust generated by mining, sandblasting, concrete cutting, and farming in dry soil, is one of the strongest occupational risk factors for lupus. A population-based study in the southeastern United States found that people with high silica exposure were 4.6 times more likely to develop lupus than unexposed individuals, with a clear dose-response pattern: medium exposure roughly doubled the risk.
Smoking appears to amplify the effect. Among people with medium-to-high silica exposure who had also smoked regularly, the odds of developing lupus jumped to 6.7 times higher than the baseline. Smoking alone was not significantly associated with lupus in that study, suggesting it acts more as a multiplier for other exposures than as an independent trigger. Silica and cigarette smoke both cause chronic, low-grade inflammation and can alter how the immune system processes damaged cells, creating conditions that favor autoimmunity in susceptible people.
Epigenetic Changes
Your genes don’t change over your lifetime, but the way they’re read can. Environmental exposures like UV light, infections, and chemical irritants can alter chemical tags on DNA that control which genes are turned on or off. In lupus, researchers consistently find that genes involved in the interferon response have lost the chemical tags (methyl groups) that normally keep them dialed down. With those brakes removed, interferon-related genes become overactive, driving the chronic immune activation that characterizes the disease.
This process, called hypomethylation, has been documented across multiple interferon-regulated genes in lupus patients of all ages. It helps explain how environmental triggers leave a lasting mark on the immune system: a viral infection or chemical exposure may resolve, but the epigenetic changes it causes can persist, keeping the immune system in a heightened state long after the original trigger is gone.
Drug-Induced Lupus
Some medications can cause a lupus-like syndrome that mimics many of the symptoms of the disease but typically resolves after the drug is stopped. Two medications carry the highest risk: procainamide (a heart rhythm drug), which causes lupus-like symptoms in about 20 percent of people who take it long-term, and hydralazine (a blood pressure medication), which triggers it in 5 to 8 percent.
Other medications associated with drug-induced lupus at lower rates include isoniazid (used for tuberculosis), minocycline (an antibiotic), and TNF-alpha inhibitors used for autoimmune conditions like rheumatoid arthritis. The timeline varies widely. Symptoms can appear as early as a week after starting a medication or as late as several years into treatment. In most cases, the condition develops after months to years of chronic use and resolves within weeks to months of stopping the drug.
Gut Bacteria and Immune Regulation
The bacterial ecosystem in the gut plays a surprisingly large role in training and regulating the immune system. People with lupus tend to have a distinct gut profile: lower overall bacterial diversity and an imbalanced ratio between two major bacterial groups, Firmicutes and Bacteroidetes. One species in particular, Ruminococcus gnavus, is found at five times higher levels in lupus patients than in healthy controls and correlates with disease activity, meaning it rises during flares.
At the same time, bacteria associated with anti-inflammatory effects, like Faecalibacterium and Roseburia, are depleted. Whether these shifts cause lupus, result from it, or both remains an open question. But the gut microbiome clearly interacts with the same immune pathways involved in lupus, and early evidence suggests that restoring microbial balance could eventually become part of managing the disease.
Who Is Most Affected
Lupus prevalence has been rising. Data from the U.S. Lupus Midwest Network shows prevalence climbed from about 31 cases per 100,000 people in 1985 to 97 per 100,000 in 2015. The disease disproportionately affects Black women, who have the highest incidence rates across all age groups. Among U.S. active-duty military members tracked from 2000 to 2022, non-Hispanic Black service members developed lupus at a rate of 10.7 per 100,000 person-years, compared to about 1.8 to 2.4 for non-Hispanic white members. Women in the military were diagnosed at a rate of 16.0 per 100,000 person-years.
These disparities reflect a combination of genetic susceptibility, socioeconomic factors that influence environmental exposures, and differences in access to early diagnosis. Hispanic and Asian American populations also face elevated risk compared to white populations, though the gap is smaller than for Black Americans. Lupus most commonly appears between the ages of 15 and 44, aligning with peak reproductive years, which further supports the role of hormonal factors in triggering the disease.